{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:06:25Z","timestamp":1762459585447,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.annder.2018.02.012","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T00:56:58Z","timestamp":1523926618000},"page":"598-602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Angi\u0153d\u00e8me bradykinique par d\u00e9ficit en C1\u00a0Inhibiteur acquis\u00a0: quatre cas"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8909-2217","authenticated-orcid":false,"given":"C.","family":"Jacquin-Porretaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Castelain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Daguindau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Seilles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Aubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2018.02.012_bib0115","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2500\/aap.2015.36.3833","article-title":"Prevalence of hereditary angioedema in untested first-degree blood relatives of known subjects with hereditary angioedema","volume":"36","author":"Riedl","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.annder.2018.02.012_bib0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.lpm.2014.09.010","article-title":"Angi\u0153d\u00e8mes bradykiniques acquis non m\u00e9dicamenteux","volume":"44","author":"Fain","year":"2015","journal-title":"Presse Med"},{"key":"10.1016\/j.annder.2018.02.012_bib0125","first-page":"183","article-title":"The angiotensin-converting-enzyme-induced angioedema","volume":"37","author":"Bas","year":"2017","journal-title":"Immunol Allergy Clin"},{"key":"10.1016\/j.annder.2018.02.012_bib0130","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.moo.0000193202.85837.7d","article-title":"Evaluation and management of angioedema of the head and neck","volume":"14","author":"Bas","year":"2006","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.annder.2018.02.012_bib0135","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jaci.2004.06.047","article-title":"Hereditary and acquired angioedema: problems and progress: proceedings of the third C1\u00a0esterase inhibitor deficiency workshop and beyond","volume":"114","author":"Agostoni","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.annder.2018.02.012_bib0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jaad.2004.09.032","article-title":"Angioedema","volume":"53","author":"Kaplan","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2018.02.012_bib0145","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(00)02596-4","article-title":"Vasopeptidase inhibition and angio-oedema","volume":"356","author":"Messerli","year":"2000","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.annder.2018.02.012_bib0150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0091-6749(96)70151-3","article-title":"Increased sensitivity to bradykinin among African Americans","volume":"98","author":"Gainer","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.annder.2018.02.012_bib0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/0003489414543069","article-title":"Angiotensin converting enzyme inhibitor-related angioedema: onset, presentation, and management","volume":"124","author":"Chan","year":"2015","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.annder.2018.02.012_bib0160","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001939","article-title":"Angioedema related to angiotensin-converting enzyme inhibitors","volume":"94","author":"Javaud","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.annder.2018.02.012_bib0165","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1097\/HJH.0b013e32834b4b9b","article-title":"Long-term follow-up of 111\u00a0patients with angiotensin-converting enzyme inhibitor-related angioedema","volume":"29","author":"Beltrami","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.annder.2018.02.012_bib0170","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.md.0000085055.63483.09","article-title":"Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies","volume":"82","author":"Cicardi","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.annder.2018.02.012_bib0175","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9343(02)01124-5","article-title":"Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2","volume":"113","author":"Fr\u00e9meaux-Bacchi","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.annder.2018.02.012_bib0180","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3324\/haematol.10769","article-title":"Lymphoproliferative disease and acquired C1\u00a0inhibitor deficiency","volume":"92","author":"Castelli","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.annder.2018.02.012_bib0185","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004363","article-title":"A nationwide study of acquired C1-inhibitor deficiency in France","volume":"95","author":"Gobert","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.annder.2018.02.012_bib0190","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s10875-012-9691-2","article-title":"Acquired C1-inhibitor deficiency: 7\u00a0patients treated with rituximab","volume":"32","author":"Branellec","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.annder.2018.02.012_bib0195","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1200\/JCO.2011.38.9957","article-title":"Acquired angioedema and marginal zone lymphoma","volume":"30","author":"Lam","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annder.2018.02.012_bib0200","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/cei.12159","article-title":"A UK national audit of hereditary and acquired angioedema","volume":"175","author":"Jolles","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.annder.2018.02.012_bib0205","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/jcp.55.10.789","article-title":"Spontaneous regression of acquired C1\u00a0esterase inhibitor deficiency associated with splenic marginal zone lymphoma presenting with recurrent angio-oedema","volume":"55","author":"Phanish","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.annder.2018.02.012_bib0210","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ajh.20195","article-title":"Lymphoma-associated paraneoplastic angioedema with normal C1-inhibitor activity: does danazol work?","volume":"77","author":"Gaur","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.annder.2018.02.012_bib0215","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/j.rce.2014.05.014","article-title":"Acquired angioedema with C1\u00a0inhibitor deficiency secondary to splenic marginal zone B-cell lymphoma","volume":"214","author":"Lara-Jim\u00e9nez","year":"2014","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.annder.2018.02.012_bib0220","first-page":"349","article-title":"Acquired C1\u00a0esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab","volume":"20","author":"Ates","year":"2015","journal-title":"J Buon"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818301327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818301327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:06:11Z","timestamp":1758971171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963818301327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0151963818301327"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2018.02.012","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angi\u0153d\u00e8me bradykinique par d\u00e9ficit en C1\u00a0Inhibiteur acquis\u00a0: quatre cas","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2018.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}